Latch

Curated by Signal

Provider of a web-based platform for genomic bioinformatics

Overview

Provider of a web-based platform for genomic bioinformatics. The company offers a biocomputing platform that enables biologists to analyze CRISPR data, and creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery.

Key facts

Founded: 2021
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

6 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

NuEar
Develops wireless and digital hearing aids
Life Sciences TechnologyEden Prairie, United States
Denovicon Therapeutics
Provider of AI-based technology for drug discovery
Life Sciences TechnologySan Diego, United States
Motif neurotech
Developer of minimally invasive bioelectronics for mental health disorders
Life Sciences TechnologyHouston, United States

About Latch

What does Latch do?

Provider of a web-based platform for genomic bioinformatics.

Where is Latch headquartered?

Latch is headquartered in San Francisco, United States.

When was Latch founded?

Latch was founded in 2021.

Which sector is Latch in?

Latch operates in Life Sciences Technology.

Who are Latch's competitors?

Companies similar to Latch include NuEar, Denovicon Therapeutics, and Motif neurotech.